Sign in / Join Now
ETFs & Funds
down 9% on failure to receive drug approval. Swann sets price target at $22.00. Buying opportunity?
Add a reply...
Latest StockTalks »
people get IPXL breaking news and analysis by email alert.
Get email alerts on IPXL »
Impax Laboratories, Inc.
Get latest price
From other sites
Impax Laboratories Enters Oversold Territory (IPXL)
at Nasdaq.com (Oct 14, 2016)
Heightened Drug Pricing Scrutiny Now A Factor In Analysts Views Of Impax Labs, Concordia International
at Benzinga (Sep 27, 2016)
Impax Launches Generic Version Of Metadate CD® (Methylphenidate Hydrochloride Extended-Release Capsules)
at TheStreet (Sep 22, 2016)
Commit To Buy Impax Laboratories At $22.50, Earn 15.8% Annualized Using Options
at Nasdaq.com (Sep 13, 2016)
Impax Provides Update On Epinephrine Injection, USP Auto-Injector
at TheStreet (Aug 30, 2016)